Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.64 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.55 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.48 |
| ▸ | TUBB | P07437 | 1/20 | 0.48 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.48 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.48 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.48 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.48 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.48 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.48 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.48 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.48 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.48 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.48 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.48 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30218817 | 0.91 | MAOA (0.55) | MAOAPDGFRBFGFR1PDGFRACA2 | |
| SCHEMBL28917930 | 0.91 | MAOA (0.55) | MAOAPDGFRBFGFR1PDGFRACA2 | |
| SCHEMBL1834224 | 0.88 | MAOA (0.61) | MAOAHDAC1TUBB4ATUBBTUBA3C | |
| Ethoxycarbonyl Group SCHEMBL27566293 | 0.86 | MAOA (0.57) | MAOAPDGFRBFGFR1PDGFRACA2 | |
| SCHEMBL3750809 | 0.86 | MAOA (0.64) | MAOAPDGFRBFGFR1PDGFRACA2 | |
| SCHEMBL17008380 | 0.84 | MAOA (0.61) | MAOAHDAC1TUBB4ATUBBTUBA3C | |
| SCHEMBL26500691 | 0.84 | MAOA (0.58) | MAOAPDGFRBFGFR1PDGFRAHDAC1 | |
| SCHEMBL13609789 | 0.84 | MAOA (0.58) | MAOAPDGFRBFGFR1PDGFRAHDAC1 | |
| SCHEMBL2013244 | 0.83 | MAOA (0.61) | MAOAHDAC1TUBB4ATUBBTUBA3C | |
| SCHEMBL29783647 | 0.83 | MAOA (0.60) | MAOAHDAC1TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719497-A1 | METHODS FOR TREATING SSTR POSITIVE CANCER | Rayzebio, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20250228842-A1 | USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME | Crinetics Pharmaceuticals, Inc. | 2025-07-17 | — | — | US | claimed |
| WO-2024249352-A1 | METHODS FOR TREATING SSTR POSITIVE CANCER | RAYZEBIO, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| EP-4463159-A1 | USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME | Crinetics Pharmaceuticals, Inc. (US) | 2024-11-20 | — | — | EP | claimed |
| WO-2023137018-A1 | USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME | Crinetics Pharmaceuticals, Inc. (US) | 2023-07-20 | — | — | WO | claimed |
| CN-114828648-A | Pet food compositions | 希尔氏宠物营养品公司 | 2022-07-29 | — | — | CN | claimed |
| US-20210198612-A1 | APPARATUS FOR ENRICHING AND SCREENING TARGET OBJECT SUCH AS CELL, BACTERIA OR BIOMOLECULE FROM SAMPLE | SUZHOU BIOFLUX MEDICAL TECHNOLOGY LTD. (CN) | 2021-07-01 | — | — | US | claimed |
| EP-3805354-A1 | APPARATUS FOR ENRICHING AND SCREENING TARGET OBJECT SUCH AS CELL, BACTERIA OR BIOMOLECULE FROM SAMPLE | Hemosmart Medical Technology Ltd. (CN) | 2021-04-14 | — | — | EP | claimed |
| EP-3551050-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | Progenity, Inc. (US) | 2019-10-16 | — | — | EP | claimed |
| EP-3551047-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | Progenity, Inc. (US) | 2019-10-16 | — | — | EP | claimed |
| US-20050181065-A1 | Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof | BIO GRAND CO., LTD. (TW) | 2005-08-18 | — | — | US | claimed |
| US-20040131595-A1 | Treating carcinoid neoplasms with therapeutic viruses | WELLSTAT BIOLOGICS CORPORATION | 2004-07-08 | — | — | US | claimed |
| WO-2004043222-A2 | TREATING CARCINOID NEOPLASMS WITH THERAPEUTHIC VIRUSES | WELLSTAT BIOLOGICS CORPORATION (US) | 2004-05-27 | — | — | WO | claimed |
| EP-0964875-B1 | 5-HYDROXYTRYPTOPHOL (5-HTOL) DERIVATIVES, ANTIBODIES, IMMUNOASSAYS AND DETECTION OF RECENT ALCOHOL CONSUMPTION | ALCO DIA AB (SE) | 2004-03-03 | — | — | EP | claimed |
| EP-1051179-A2 | ANTI-ESTROGEN PLUS PROGESTIN CONTAINING ORAL CONTRACEPTIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-15 | — | — | EP | claimed |
| EP-0964875-A1 | 5-HYDROXYTRYPTOPHOL (5-HTOL) DERIVATIVES, ANTIBODIES, IMMUNOASSAYS AND DETECTION OF RECENT ALCOHOL CONSUMPTION | Axis Biochemicals ASA (NO) | 1999-12-22 | — | — | EP | claimed |
| WO-1999024027-A2 | ANTI-ESTROGEN PLUS PROGESTIN CONTAINING ORAL CONTRACEPTIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-05-20 | — | — | WO | claimed |
| WO-1998024819-A1 | 5-HYDROXYTRYPTOPHOL (5-HTOL) DERIVATIVES, ANTIBODIES, IMMUNOASSAYS AND DETECTION OF RECENT ALCOHOL CONSUMPTION | AXIS BIOCHEMICALS ASA (NO) | 1998-06-11 | — | — | WO | claimed |
| EP-0006792-B1 | IODINATED COMPOUND USABLE AS RADIO-IMMUNOLOGICAL TRACER AND ITS PROCESS OF PREPARATION | COMMISSARIAT A L'ENERGIE ATOMIQUE Etablissement de Caractère Scientifique Technique et Industriel (FR) | 1982-06-23 | — | — | EP | claimed |
| US-4331646-A | Iodine compound for use as a tracer in radioimmunology | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1982-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228842-A1 | USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME | SSTR4, SSTR5, SSTR2 | MAOA 3686/4885PDGFRB 625/4885FGFR1 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.